David Silberman Oramed Pharmaceuticals Inc. (ORMP) insider trading activity

ORMP Quotes by TradingView

David Silberman is Chief Financial Officer of ORAMED PHARMACEUTICALS INC.. Currently has a direct ownership of 366,500 shares of ORMP, which is worth approximately $886,930. The most recent transaction as insider was on Jan 04, 2024, when has been sold 136,500 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 367K
0% 3M change
59.35% 12M change
Total Value Held $886,930

David Silberman Transaction History

Date Transaction Value Shares Traded Shares Held Form
Jan 04 2024
BUY
Grant, award, or other acquisition
-
136,500 Added 27.14%
366,500 Common Stock
May 26 2023
BUY
Grant, award, or other acquisition
-
24,500 Added 9.63%
230,000 Common Stock
Apr 17 2023
BUY
Grant, award, or other acquisition
-
97,500 Added 32.18%
205,500 Common Stock
Jul 28 2022
BUY
Grant, award, or other acquisition
-
39,000 Added 26.53%
108,000 Common Stock
Jan 03 2022
BUY
Grant, award, or other acquisition
-
19,000 Added 21.59%
69,000 Common Stock
Sep 01 2021
BUY
Grant, award, or other acquisition
-
50,000 Added 50.0%
50,000 Common Stock
DS

David Silberman

Chief Financial Officer
Jerusalem, L3

Track Institutional and Insider Activities on ORMP

Follow ORAMED PHARMACEUTICALS INC. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells ORMP shares.

Notify only if

Insider Trading

Get notified when an Oramed Pharmaceuticals Inc. insider buys or sells ORMP shares.

Notify only if

News

Receive news related to ORAMED PHARMACEUTICALS INC.

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on ORMP